Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The association between synovial fluid serine proteinase activity and response to intra-articular corticosteroid injection in psoriatic arthritis.

Abji F, Ye JY, Cook RJ, Oikonomopoulou K, Chandran V.

Clin Rheumatol. 2020 Feb 25. doi: 10.1007/s10067-020-05003-9. [Epub ahead of print]

PMID:
32100195
2.

Proteinases and their receptors in inflammatory arthritis: an overview.

Oikonomopoulou K, Diamandis EP, Hollenberg MD, Chandran V.

Nat Rev Rheumatol. 2018 Mar;14(3):170-180. doi: 10.1038/nrrheum.2018.17. Epub 2018 Feb 8. Review.

PMID:
29416136
3.

Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery.

Mahendran SM, Oikonomopoulou K, Diamandis EP, Chandran V.

Crit Rev Clin Lab Sci. 2017 Nov - Dec;54(7-8):495-505. doi: 10.1080/10408363.2017.1408561. Epub 2017 Dec 4. Review.

PMID:
29202618
4.

Association between Echinococcus granulosus infection and cancer risk - a pilot study in Cyprus.

Oikonomopoulou K, Yu H, Wang Z, Vasiliou SK, Brinc D, Christofi G, Theodorou M, Pavlou P, Hadjisavvas A, Demetriou CA, Kyriacou K, Diamandis EP.

Clin Chem Lab Med. 2016 Dec 1;54(12):1955-1961. doi: 10.1515/cclm-2016-0125.

PMID:
27327131
5.

Proteinases, Their Extracellular Targets, and Inflammatory Signaling.

Ramachandran R, Altier C, Oikonomopoulou K, Hollenberg MD.

Pharmacol Rev. 2016 Oct;68(4):1110-1142. Review.

PMID:
27677721
6.

Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Muytjens CM, Vasiliou SK, Oikonomopoulou K, Prassas I, Diamandis EP.

Nat Rev Urol. 2016 Oct;13(10):596-607. doi: 10.1038/nrurol.2016.161. Epub 2016 Sep 7. Review.

PMID:
27603220
7.

Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.

Walker F, Nicole P, Jallane A, Soosaipillai A, Mosbach V, Oikonomopoulou K, Diamandis EP, Magdolen V, Darmoul D.

Biol Chem. 2014 Sep;395(9):1075-86. doi: 10.1515/hsz-2014-0142.

PMID:
25153388
8.

The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms.

Oikonomopoulou K, Brinc D, Hadjisavvas A, Christofi G, Kyriacou K, Diamandis EP.

Crit Rev Clin Lab Sci. 2014 Jun;51(3):138-48. doi: 10.3109/10408363.2014.886180. Epub 2014 Mar 4. Review.

PMID:
24588712
9.

Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Oikonomopoulou K, DeAngelis RA, Chen H, Diamandis EP, Hollenberg MD, Ricklin D, Lambris JD.

J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6.

10.

Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice.

Fisette A, Poursharifi P, Oikonomopoulou K, Munkonda MN, Lapointe M, Cianflone K.

Mediators Inflamm. 2013;2013:713284. doi: 10.1155/2013/713284. Epub 2013 May 12.

11.

Infection and cancer: revaluation of the hygiene hypothesis.

Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP.

Clin Cancer Res. 2013 Jun 1;19(11):2834-41. doi: 10.1158/1078-0432.CCR-12-3661. Epub 2013 Mar 27. Review.

12.

C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice.

Fisette A, Munkonda MN, Oikonomopoulou K, Paglialunga S, Lambris JD, Cianflone K.

Immunobiology. 2013 Jan;218(1):127-33. doi: 10.1016/j.imbio.2012.04.001. Epub 2012 Apr 21.

PMID:
22622332
13.

Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14.

Ramachandran R, Eissa A, Mihara K, Oikonomopoulou K, Saifeddine M, Renaux B, Diamandis E, Hollenberg MD.

Biol Chem. 2012 Apr;393(5):421-7. doi: 10.1515/hsz-2011-0251.

PMID:
22505524
14.

Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.

Chung H, Hamza M, Oikonomopoulou K, Gratio V, Saifeddine M, Virca GD, Diamandis EP, Hollenberg MD, Darmoul D.

Biol Chem. 2012 Apr;393(5):413-20. doi: 10.1515/bc-2011-231.

PMID:
22505523
15.

Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.

Gratio V, Loriot C, Virca GD, Oikonomopoulou K, Walker F, Diamandis EP, Hollenberg MD, Darmoul D.

Am J Pathol. 2011 Nov;179(5):2625-36. doi: 10.1016/j.ajpath.2011.07.016. Epub 2011 Sep 9.

16.

Interactions between coagulation and complement--their role in inflammation.

Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD.

Semin Immunopathol. 2012 Jan;34(1):151-65. doi: 10.1007/s00281-011-0280-x. Epub 2011 Aug 3. Review.

17.

Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.

Guillon-Munos A, Oikonomopoulou K, Michel N, Smith CR, Petit-Courty A, Canepa S, Reverdiau P, Heuzé-Vourc'h N, Diamandis EP, Courty Y.

J Biol Chem. 2011 Jul 22;286(29):25505-18. doi: 10.1074/jbc.M110.213231. Epub 2011 May 31.

18.

Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients.

Blanco I, Béritze N, Argüelles M, Cárcaba V, Fernández F, Janciauskiene S, Oikonomopoulou K, de Serres FJ, Fernández-Bustillo E, Hollenberg MD.

Clin Rheumatol. 2010 Dec;29(12):1403-12. doi: 10.1007/s10067-010-1474-7. Epub 2010 Apr 30.

PMID:
20428906
19.

Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.

Oikonomopoulou K, Batruch I, Smith CR, Soosaipillai A, Diamandis EP, Hollenberg MD.

Biol Chem. 2010 Apr;391(4):381-90. doi: 10.1515/BC.2010.045.

PMID:
20180649
20.

Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.

Oikonomopoulou K, Diamandis EP, Hollenberg MD.

Biol Chem. 2010 Apr;391(4):299-310. doi: 10.1515/BC.2010.038. Review.

PMID:
20180639
21.

Prognostic impact of CD68 and kallikrein 6 in human glioma.

Strojnik T, Kavalar R, Zajc I, Diamandis EP, Oikonomopoulou K, Lah TT.

Anticancer Res. 2009 Aug;29(8):3269-79.

22.

Evaluation of prostate-specific antigen as a novel biomarker of Hsp90 inhibition.

Oikonomopoulou K, Soosaipillai A, Diamandis EP.

Clin Biochem. 2009 Nov;42(16-17):1705-12. doi: 10.1016/j.clinbiochem.2009.07.018. Epub 2009 Jul 23.

PMID:
19632215
23.

Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.

Sharma N, Oikonomopoulou K, Ito K, Renaux B, Diamandis EP, Hollenberg MD, Rancourt DE.

Biol Chem. 2008 Aug;389(8):1097-105.

PMID:
18979633
24.

Proteinases as hormones: targets and mechanisms for proteolytic signaling.

Hansen KK, Oikonomopoulou K, Baruch A, Ramachandran R, Beck P, Diamandis EP, Hollenberg MD.

Biol Chem. 2008 Aug;389(8):971-82. doi: 10.1515/BC.2008.120. Review.

PMID:
18979623
25.

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

Oikonomopoulou K, Li L, Zheng Y, Simon I, Wolfert RL, Valik D, Nekulova M, Simickova M, Frgala T, Diamandis EP.

Br J Cancer. 2008 Oct 7;99(7):1103-13. doi: 10.1038/sj.bjc.6604630. Epub 2008 Sep 2.

26.

Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.

Hollenberg MD, Oikonomopoulou K, Hansen KK, Saifeddine M, Ramachandran R, Diamandis EP.

Biol Chem. 2008 Jun;389(6):643-51. doi: 10.1515/BC.2008.077. Review.

PMID:
18627296
27.

Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids.

Oikonomopoulou K, Hansen KK, Baruch A, Hollenberg MD, Diamandis EP.

Biol Chem. 2008 Jun;389(6):747-56. doi: 10.1515/BC.2008.086.

PMID:
18627291
28.

Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Hansen KK, Oikonomopoulou K, Li Y, Hollenberg MD.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):377-92. Epub 2007 Oct 19. Review.

PMID:
17952408
29.

Mass spectrometry: uncovering the cancer proteome for diagnostics.

van der Merwe DE, Oikonomopoulou K, Marshall J, Diamandis EP.

Adv Cancer Res. 2007;96:23-50. Review.

PMID:
17161675
30.

Proteinase-activated receptors, targets for kallikrein signaling.

Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI, Scarisbrick I, Andrade-Gordon P, Cottrell GS, Bunnett NW, Diamandis EP, Hollenberg MD.

J Biol Chem. 2006 Oct 27;281(43):32095-112. Epub 2006 Aug 2.

31.

Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).

Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Blaber M, Blaber SI, Scarisbrick I, Diamandis EP, Hollenberg MD.

Biol Chem. 2006 Jun;387(6):817-24.

PMID:
16800746
32.

Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.

Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, Diamandis EP, Hollenberg MD.

Biol Chem. 2006 Jun;387(6):677-85. Review.

PMID:
16800728
33.

Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.

Oikonomopoulou K, Scorilas A, Michael IP, Grass L, Soosaipillai A, Rosen B, Murphy J, Diamandis EP.

Tumour Biol. 2006;27(2):104-14. Epub 2006 Mar 24.

PMID:
16557045
34.

In silico analysis of the human kallikrein gene 6.

Yousef GM, Borgoño CA, White NM, Robb JD, Michael IP, Oikonomopoulou K, Khan S, Diamandis EP.

Tumour Biol. 2004 Sep-Dec;25(5-6):282-9.

PMID:
15627893

Supplemental Content

Loading ...
Support Center